Canadian Cardiovascular Society
Canadian Perspectives

Canadian Perspectives on the ACC 2023 – Session 2

Starts: May 10, 2023 8:00 p.m. EDT

Ends: May 10, 2023 9:00 p.m. EDT

Royal College MOC Credits: 1

https://register.gotowebinar.com/register/474916883972908636 Opens in a new window

Learning Objectives

  • Review new data relevant to clinical practice (Leader, Collaborator, Professional, Expert, Communicator, Scholar)
  • Discuss the latest clinical trial data from ACC 2023 and apply it to daily practice ((Leader, Collaborator, Professional, Expert, Communicator, Scholar)

Speakers

  • Moderated by: Dr. Anil Gupta
  • Dr. Anita Asgar
  • Dr. Robert Hegele

Agenda

8:00 – 8:05 PM EDT – Introduction to the program and faculty
8:05 – 8:35 PM EDT – Trial summaries
8:35 – 9:00 PM EDT – Panel discussion on the applicability and implications of the trials

Trial Topics

  • Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen – CLEAR Outcomes
  • Trial to Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal – TRILUMINATE Pivotal
  • Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial

https://register.gotowebinar.com/register/474916883972908636 Opens in a new window

Back to top